Late relapse of a light-chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem-cell transplantation.
We present a rare experience with a myeloma patient who had a late relapse as isolated extramedullary plasmacytoma of the thyroid gland after a second allogeneic transplantation. We give PET/CT scan findings at diagnosis and during follow up of the disease after subsequent management. The possible pathogenesis of the late extramedullary relapse of myeloma after allogeneic stem-cell transplantation and management options are discussed.
Ozdemir
Evren
E
Stem Cell Transplantation Unit, Hacettepe University Institute of Oncology, Ankara, Turkey. dreozdemir@yahoo.com
Bayraktar
Miyase
M
Sökmensüer
Cenk
C
Kir
K Metin
KM
Kansu
Emin
E
D001706:Biopsy; D005500:Follow-Up Studies; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000378:metabolism; D010954:Plasmacytoma / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D049268:Positron-Emission Tomography; D011379:Prognosis; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D013997:Time Factors; D014184:Transplantation, Homologous
D007145:Immunoglobulin kappa-Chains